These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 8944605)
1. Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatment? Williams CP; Child DF; Hudson PR; Soysa LD; Davies GK; Davies MG; De Bolla AR J Clin Pathol; 1996 Nov; 49(11):881-8. PubMed ID: 8944605 [TBL] [Abstract][Full Text] [Related]
2. The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients. Irzyniec T; Boryń M; Kasztalska J; Nowak-Kapusta Z; Maciejewska-Paszek I; Grochowska-Niedworok E Clin Nutr; 2020 Dec; 39(12):3804-3812. PubMed ID: 32386861 [TBL] [Abstract][Full Text] [Related]
3. Renal phosphate leak in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Negri AL; Spivacow R; Del Valle E; Fradinger E; Marino A; Zanchetta JR Urol Res; 2003 Dec; 31(6):378-81. PubMed ID: 13680023 [TBL] [Abstract][Full Text] [Related]
4. [Renal tubular function in children with hypercalciuria]. Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386 [TBL] [Abstract][Full Text] [Related]
5. Phosphate metabolism in renal stone formers. (II): Relation to renal tubular functions and calcium metabolism. Wikström B; Backman U; Danielson BG; Fellström B; Johansson G; Ljunghall S; Wide L Scand J Urol Nephrol Suppl; 1981; 61():II:1-26. PubMed ID: 6274002 [TBL] [Abstract][Full Text] [Related]
7. Proximal tubular defects in idiopathic hypercalciuria: resistance to phosphate administration. Lau YK; Wasserstein A; Westby GR; Bosanac P; Grabie M; Mitnick P; Slatopolsky E; Goldfarb S; Agus ZS Miner Electrolyte Metab; 1982; 7(5):237-49. PubMed ID: 7169988 [TBL] [Abstract][Full Text] [Related]
8. Why oral calcium supplements may reduce renal stone disease: report of a clinical pilot study. Williams CP; Child DF; Hudson PR; Davies GK; Davies MG; John R; Anandaram PS; De Bolla AR J Clin Pathol; 2001 Jan; 54(1):54-62. PubMed ID: 11271790 [TBL] [Abstract][Full Text] [Related]
9. Renal threshold phosphate concentration in patients with idiopathic nephrolithiasis: correlations with tubular functions, serum parathyroid hormone and 1,25(OH)2D3. Pabico RC; McKenna BA; Freeman RB Proc Eur Dial Transplant Assoc; 1983; 20():450-4. PubMed ID: 6689210 [TBL] [Abstract][Full Text] [Related]
10. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria. Pak CY; Oata M; Lawrence EC; Snyder W J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891 [TBL] [Abstract][Full Text] [Related]
11. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients. Caravaca F; Fernández MA; Ruiz-Calero R; Cubero J; Aparicio A; Jimenez F; García MC Nephrol Dial Transplant; 1998 Oct; 13(10):2605-11. PubMed ID: 9794568 [TBL] [Abstract][Full Text] [Related]
12. Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Prié D; Ravery V; Boccon-Gibod L; Friedlander G Kidney Int; 2001 Jul; 60(1):272-6. PubMed ID: 11422761 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk? Johri N; Jaeger P; Ferraro PM; Shavit L; Nair D; Robertson WG; Gambaro G; Unwin RJ Urolithiasis; 2017 Dec; 45(6):535-543. PubMed ID: 27981376 [TBL] [Abstract][Full Text] [Related]
15. Influence of dietary calcium on serum 1,25-dihydroxyvitamin D concentrations in renal stone formers. D'Amour P; Gascon-Barré M; Dufresne L; Perreault JP Clin Endocrinol (Oxf); 1984 Nov; 21(5):549-62. PubMed ID: 6094046 [TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
17. Renal clearance of phosphate and calcium in vitamin D-deficient chicks: effect of calcium loading, parathyroidectomy, and parathyroid hormone administration. Clark NB J Exp Zool; 1991 Aug; 259(2):188-95. PubMed ID: 1664453 [TBL] [Abstract][Full Text] [Related]
18. Simplified protocol for biochemical evaluation of recurrent renal calcium stone disease. Thode J; Finnerup B; Parvin C; Holmegaard SN; Skaarup P; Sørensen OH; Transbøl I Miner Electrolyte Metab; 1988; 14(5):288-96. PubMed ID: 2845241 [TBL] [Abstract][Full Text] [Related]
19. Has vitamin D a direct renal effect on the tubular reabsorption of phosphate? A study in parathyroidectomized (PTX) and non-PTX man. Madsen S; Olgaard K Adv Exp Med Biol; 1978; 103():111-23. PubMed ID: 717102 [TBL] [Abstract][Full Text] [Related]
20. An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors. Shakhssalim N; Gilani KR; Parvin M; Torbati PM; Kashi AH; Azadvari M; Golestan B; Basiri A Urol Res; 2011 Feb; 39(1):1-7. PubMed ID: 20490785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]